A carregar...

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes

Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Diabetes
Autor principal: Neumiller, Joshua J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220591/
https://ncbi.nlm.nih.gov/pubmed/25646943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaclin.32.4.170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!